Most Adults Lack Knowledge About Pancreatic Cancer
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, Nov. 5, 2024 -- Most people continue to believe that pancreatic cancer affects only the elderly and that there is nothing they can do to reduce their risk, according to the results of a new survey from The Ohio State University.
A national web- and telephone-based survey (Oct. 4 to 7) of 1,004 respondents was conducted by The Ohio State University Comprehensive Cancer Center (OSUCCC) Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
More than half of adults younger than 50 years (53 percent) said they would not recognize the early signs or symptoms of pancreatic cancer. Roughly one-third of respondents said there is nothing they can do to change their risk for the disease (37 percent) and that only older adults are at risk (33 percent). Just over half of survey respondents (54 percent) knew that genetic testing could help them understand if they should be screened for pancreatic cancer.
"This disease is too often a silent killer, with no symptoms until it has progressed to less treatable stages," Zobeida Cruz-Monserrate, Ph.D., co-leader of the OSUCCC James Molecular Carcinogenesis and Chemoprevention Program, said in a statement. "We must continue to aggressively pursue research that will help us prevent, diagnose, and treat this disease more effectively."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-06 12:00
Read more
- Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria
- Clinical Practice Guideline Updated for Migraine, Tension-Type Headache
- Exposure to Inorganic Arsenic in Drinking Water Increases Cardiovascular Risk
- More Bystanders Are Using Naloxone to Save Folks From Overdose
- Think Your Opinion Must Be Right? Science Reveals Why You May Be Wrong
- Volixibat Granted Breakthrough Therapy Designation for Cholestatic Pruritus in Primary Biliary Cholangitis
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions